Neonious Biotech

We are pioneers of in silico prediction of drug safety and adverse reactions, limiting cost risks and reducing harm done to animals and humans.

To have the best tools for our drug analysis, we constantly optimize algorithms and pipelines and grow our distributed network which is a cost-efficient source for the needed computing power.

Our research is powered by the Neonious Network
and the Neonious Token (MDSIM).

Neonious is contracted to help to assess a drug for safety and adverse reactions.

Besides manual analysis, Neonious' research team utilizes computational pipelines

These pipelines queue simulations (docking + MD) to be run by the Neonious Network, paid with MDSIMs.

Sombody running the Neonious software, thus being part of the Neonious Network, runs the simulations.

This person is rewarded with easy transferable MDSIMs, which he or her can exchange for real money.

We believe it is beneficial to reduce risks by contract us to analyse your drug, preferable before starting preclinical research, latest before phase 2 of the human trials.

For lower cost, we can utilize the Neonious Network. Alternatively, the calculations can also be done on more private computing resources